Hologic has signed a definitive agreement to acquire Reveal Genomics, a Barcelona-based precision oncology company developing ...

A new few-shot learning framework called scCAPReSE detects large-scale genomic rearrangements in single-cell Hi-C data using ...

Cancer genomics is the study of the totality of DNA sequence and gene expression differences between tumour cells and normal host cells. It aims to understand the genetic basis of tumour cell ...

A prospective trial found constitutional pathogenic variants in about 10 percent of solid tumor patients screened through ...

CLEVELAND, Ohio — A genomic test used to assess prostate cancer risk may also help doctors determine which patients are ...

The immune system may recognize a cancer cell and still fail to destroy it. In a recent study, researchers at Hiroshima ...

UBC medical genetics professor Dr. Marco Marra joins us to discuss 'Powered by Terry', a new claymation film celebrating ...

OPTIMA shows Prosigna assay can help many ER-positive, HER2-negative breast cancer patients safely avoid chemotherapy.

The initiative represents the first time 10x Genomics widened its scope past solid tumours to include haematologic malignancies.

At the Big Ten CRC Summit, VK Gadi, MD, PhD, explained why functional drug testing and genomic profiling should be used ...

Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among the large number of variants of uncertain significance (VUS) detected in ...

For two decades, cancer genomic data has underpinned many of the most important discoveries in cancer genomics. However, most studies have relied primarily on whole-exome sequencing (WES), which ...